Clinical Trial Update: Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on establishing a controlled human infection model using pertactin-deficient Bordetella pertussis to study pertussis; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• Pertactin-deficient Bordetella pertussis (CHIM challenge agent) (Pertactin-deficient Bordetella pertussis)

Snippet

Sponsor: Dalhousie University | Conditions: Pertussis (Whooping Cough) | Phase 1 | Status: RECRUITING